| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |